{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:59:13Z","timestamp":1774648753689,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T00:00:00Z","timestamp":1468886400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12876-016-0481-9","type":"journal-article","created":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T19:00:39Z","timestamp":1468868439000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"16","author":[{"given":"Vinod S.","family":"Hegade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart F. W.","family":"Kendrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Dobbins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam R.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duncan","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Storey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Dukes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Gilchrist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Vallow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme J.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Corrigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gideon M.","family":"Hirschfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E. J.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,19]]},"reference":[{"issue":"3","key":"481_CR1","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1055\/s-0034-1383730","volume":"34","author":"L Griffiths","year":"2014","unstructured":"Griffiths L, Dyson JK, Jones DE. The new epidemiology of primary biliary cirrhosis. Semin Liver Dis. 2014;34(3):318\u201328. doi: 10.1055\/s-0034-1383730 . published Online First: Epub Date.","journal-title":"Semin Liver Dis"},{"issue":"2","key":"481_CR2","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","volume":"51","author":"U Beuers","year":"2009","unstructured":"Beuers U, Boberg KM, Chapman RW, et al. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51(2):237\u201367. doi: 10.1016\/j.jhep.2009.04.009 . published Online First: Epub Date.","journal-title":"J Hepatol"},{"key":"481_CR3","doi-asserted-by":"publisher","first-page":"339A","DOI":"10.1002\/hep.27496","volume":"60","author":"VS Hegade","year":"2014","unstructured":"Hegade VS, Mells GF, Beuers U, et al. Patient Experience and Characteristics of Cholestatic Pruritus in the UK-PBC Research Cohort. Hepatology. 2014;60:339A\u201369. doi: 10.1002\/hep.27496 . published Online First: Epub Date.","journal-title":"Hepatology"},{"key":"481_CR4","doi-asserted-by":"publisher","first-page":"S785","DOI":"10.1016\/S0168-8278(15)31349-0","volume":"62","author":"VS Hegade","year":"2015","unstructured":"Hegade VS, Mells GF, Lammert C, et al. A Comparative Study of Pruritus in PBC cohorts from UK, USA and Italy. J Hepatol. 2015;62:S785.","journal-title":"J Hepatol"},{"issue":"1","key":"481_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/hep.26365","volume":"58","author":"GF Mells","year":"2013","unstructured":"Mells GF, Pells G, Newton JL, et al. Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study. Hepatology. 2013;58(1):273\u201383. doi: 10.1002\/hep.26365 . published Online First: Epub Date.","journal-title":"Hepatology"},{"issue":"1","key":"481_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/hep.22906","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, Gershwin ME, Poupon R, et al. Primary biliary cirrhosis. Hepatology. 2009;50(1):291\u2013308. doi: 10.1002\/hep.22906 . published Online First: Epub Date.","journal-title":"Hepatology"},{"issue":"1","key":"481_CR7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jhep.2014.09.010","volume":"62","author":"JK Dyson","year":"2015","unstructured":"Dyson JK, Webb G, Hirschfield GM, et al. Unmet clinical need in autoimmune liver diseases. J Hepatol. 2015;62(1):208\u201318. doi: 10.1016\/j.jhep.2014.09.010 . published Online First: Epub Date.","journal-title":"J Hepatol"},{"issue":"36","key":"481_CR8","doi-asserted-by":"publisher","first-page":"33920","DOI":"10.1074\/jbc.M306370200","volume":"278","author":"PA Dawson","year":"2003","unstructured":"Dawson PA, Haywood J, Craddock AL, et al. Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice. J Biol Chem. 2003;278(36):33920\u20137. doi: 10.1074\/jbc.M306370200 . published Online First: Epub Date.","journal-title":"J Biol Chem"},{"issue":"9","key":"481_CR9","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1136\/gut.52.9.1371","volume":"52","author":"A Lanzini","year":"2003","unstructured":"Lanzini A, De Tavonatti MG, Panarotto B, et al. Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration. Gut. 2003;52(9):1371\u20135.","journal-title":"Gut"},{"issue":"2","key":"481_CR10","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/apt.13449","volume":"43","author":"VS Hegade","year":"2016","unstructured":"Hegade VS, Krawczyk M, Kremer AE, et al. The safety and efficacy of nasobiliary drainage in the treatment of refractory cholestatic pruritus: a multicentre European study. Aliment Pharmacol Ther. 2016;43(2):294\u2013302. doi: 10.1111\/apt.13449 . published Online First: Epub Date.","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"481_CR11","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1097\/00042737-200111000-00022","volume":"13","author":"J Neuberger","year":"2001","unstructured":"Neuberger J, Jones EA. Liver transplantation for intractable pruritus is contraindicated before an adequate trial of opiate antagonist therapy. Eur J Gastroenterol Hepatol. 2001;13(11):1393\u20134.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"45","key":"481_CR12","doi-asserted-by":"publisher","first-page":"27228","DOI":"10.1074\/jbc.270.45.27228","volume":"270","author":"MH Wong","year":"1995","unstructured":"Wong MH, Oelkers P, Dawson PA. Identification of a mutation in the ileal sodium-dependent bile acid transporter gene that abolishes transport activity. J Biol Chem. 1995;270(45):27228\u201334.","journal-title":"J Biol Chem"},{"issue":"3","key":"481_CR13","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jhep.2015.10.024","volume":"64","author":"A Baghdasaryan","year":"2016","unstructured":"Baghdasaryan A, Fuchs CD, Osterreicher CH, et al. Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis. J Hepatol. 2016;64(3):674\u201381. doi: 10.1016\/j.jhep.2015.10.024 . published Online First: Epub Date.","journal-title":"J Hepatol"},{"issue":"2","key":"481_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/apt.13457","volume":"43","author":"H Graffner","year":"2016","unstructured":"Graffner H, Gillberg PG, Rikner L, Marschall HU. The ileal bile acid transporter inhibitor A4250 decreases serum bile acids by interrupting the enterohepatic circulation. Aliment Pharmacol Ther. 2016;43(2):303\u201310. doi: 10.1111\/apt.13457 . published Online First: Epub Date.","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"481_CR15","doi-asserted-by":"publisher","first-page":"e007985","DOI":"10.1136\/bmjopen-2015-007985","volume":"5","author":"L Jopson","year":"2015","unstructured":"Jopson L, Newton JL, Palmer J, et al. RITPBC: B-cell depleting therapy (rituximab) as a treatment for fatigue in primary biliary cirrhosis: study protocol for a randomised controlled trial. BMJ Open. 2015;5(8):e007985. doi: 10.1136\/bmjopen-2015-007985 . published Online First: Epub Date.","journal-title":"BMJ Open"},{"issue":"11","key":"481_CR16","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1136\/gut.2005.065862","volume":"54","author":"A Jacoby","year":"2005","unstructured":"Jacoby A, Rannard A, Buck D, et al. Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis. Gut. 2005;54(11):1622\u20139. doi: 10.1136\/gut.2005.065862 . published Online First: Epub Date.","journal-title":"Gut"},{"issue":"3","key":"481_CR17","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1365-2133.2009.09586.x","volume":"162","author":"S Elman","year":"2010","unstructured":"Elman S, Hynan LS, Gabriel V, Mayo MJ. The 5-D itch scale: a new measure of pruritus. Br J Dermatol. 2010;162(3):587\u201393. doi: 10.1111\/j.1365-2133.2009.09586.x . published Online First: Epub Date.","journal-title":"Br J Dermatol"},{"issue":"8","key":"481_CR18","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/j.1478-3231.2006.01326.x","volume":"26","author":"S Khurana","year":"2006","unstructured":"Khurana S, Singh P. Rifampin is safe for treatment of pruritus due to chronic cholestasis: a meta-analysis of prospective randomized-controlled trials. Liver Int. 2006;26(8):943\u20138. doi: 10.1111\/j.1478-3231.2006.01326.x . published Online First: Epub Date.","journal-title":"Liver Int"},{"issue":"7","key":"481_CR19","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1111\/j.1572-0241.2007.01200.x","volume":"102","author":"P Tandon","year":"2007","unstructured":"Tandon P, Rowe BH, Vandermeer B, Bain VG. The efficacy and safety of bile Acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus. Am J Gastroenterol. 2007;102(7):1528\u201336. doi: 10.1111\/j.1572-0241.2007.01200.x . published Online First: Epub Date.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"481_CR20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0016-5085(66)80071-9","volume":"50","author":"DV Datta","year":"1966","unstructured":"Datta DV, Sherlock S. Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis. Gastroenterology. 1966;50(3):323\u201332.","journal-title":"Gastroenterology"},{"issue":"4","key":"481_CR21","first-page":"599","volume":"1","author":"ZH Oster","year":"1965","unstructured":"Oster ZH, Rachmilewitz EA, Moran E, Stein Y. Relief of pruritus by cholestyramine in chronic liver disease. Isr J Med Sci. 1965;1(4):599\u2013606.","journal-title":"Isr J Med Sci"},{"issue":"5325","key":"481_CR22","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1136\/bmj.1.5325.216","volume":"1","author":"DV Datta","year":"1963","unstructured":"Datta DV, Sherlock S. Treatment of pruritus of obstructive jaundice with cholestyramine. Br Med J. 1963;1(5325):216\u20139.","journal-title":"Br Med J"},{"key":"481_CR23","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1056\/NEJM196109072651004","volume":"265","author":"TB Itallie Van","year":"1961","unstructured":"Van Itallie TB, Hashim SA, Crampton RS, Tennent DM. The treatment of pruritus and hypercholesteremia of primary biliary cirrhosis with cholestyramine. N Engl J Med. 1961;265:469\u201374. doi: 10.1056\/NEJM196109072651004 . published Online First: Epub Date.","journal-title":"N Engl J Med"},{"key":"481_CR24","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1001\/jama.1961.03040180034008","volume":"176","author":"JB Carey Jr","year":"1961","unstructured":"Carey Jr JB, Williams G. Relief of the pruritus of jaundice with a bile-acid sequestering resin. JAMA. 1961;176:432\u20135.","journal-title":"JAMA"},{"issue":"6","key":"481_CR25","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0168-8278(02)00318-5","volume":"37","author":"R Terg","year":"2002","unstructured":"Terg R, Coronel E, Sorda J, Munoz AE, Findor J. Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study. J Hepatol. 2002;37(6):717\u201322.","journal-title":"J Hepatol"},{"issue":"4","key":"481_CR26","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/gast.1997.v113.pm9322521","volume":"113","author":"FH Wolfhagen","year":"1997","unstructured":"Wolfhagen FH, Sternieri E, Hop WC, Vitale G, Bertolotti M, Van Buuren HR. Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study. Gastroenterology. 1997;113(4):1264\u20139.","journal-title":"Gastroenterology"},{"issue":"2","key":"481_CR27","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/0016-5085(88)90442-8","volume":"94","author":"CN Ghent","year":"1988","unstructured":"Ghent CN, Carruthers SG. Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial. Gastroenterology. 1988;94(2):488\u201393.","journal-title":"Gastroenterology"},{"issue":"3","key":"481_CR28","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/hep.21553","volume":"45","author":"MJ Mayo","year":"2007","unstructured":"Mayo MJ, Handem I, Saldana S, Jacobe H, Getachew Y, Rush AJ. Sertraline as a first-line treatment for cholestatic pruritus. Hepatology. 2007;45(3):666\u201374. doi: 10.1002\/hep.21553 . published Online First: Epub Date.","journal-title":"Hepatology"},{"issue":"5","key":"481_CR29","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21370","volume":"44","author":"NV Bergasa","year":"2006","unstructured":"Bergasa NV, McGee M, Ginsburg IH, Engler D. Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial. Hepatology. 2006;44(5):1317\u201323. doi: 10.1002\/hep.21370 . published Online First: Epub Date.","journal-title":"Hepatology"},{"issue":"4","key":"481_CR30","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1002\/hep.23821","volume":"52","author":"EM Kuiper","year":"2010","unstructured":"Kuiper EM, van Erpecum KJ, Beuers U, et al. The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: results of a double-blind, randomized, placebo-controlled trial. Hepatology. 2010;52(4):1334\u201340. doi: 10.1002\/hep.23821 . published Online First: Epub Date.","journal-title":"Hepatology"},{"issue":"4","key":"481_CR31","doi-asserted-by":"publisher","first-page":"351","DOI":"10.7861\/clinmedicine.15-4-351","volume":"15","author":"VS Hegade","year":"2015","unstructured":"Hegade VS, Kendrick SF, Jones DE. Drug treatment of pruritus in liver diseases. Clin Med. 2015;15(4):351\u20137. doi: 10.7861\/clinmedicine.15-4-351 . published Online First: Epub Date.","journal-title":"Clin Med"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-016-0481-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-016-0481-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-016-0481-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-016-0481-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T06:11:52Z","timestamp":1568182312000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-016-0481-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,19]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["481"],"URL":"https:\/\/doi.org\/10.1186\/s12876-016-0481-9","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,19]]},"article-number":"71"}}